These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7795167)

  • 41. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches.
    Suba EJ; Donnelly AD; Furia LM; Huynh ML; Raab SS;
    Diagn Cytopathol; 2007 Mar; 35(3):187-91. PubMed ID: 17304532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cervical cancer screening in Switzerland - current practice and future challenges].
    Untiet S; Schmidt N; Low N; Petignat P
    Ther Umsch; 2013 Apr; 70(4):223-30. PubMed ID: 23535549
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical cancer vaccine prospects.
    World Health Forum; 1994; 15(4):417. PubMed ID: 7999245
    [No Abstract]   [Full Text] [Related]  

  • 44. Knowledge, attitudes and practices of rural women in South Africa regarding the Pap smear.
    Lartey M; Joubert G; Cronje HS
    Int J Gynaecol Obstet; 2003 Dec; 83(3):315-6. PubMed ID: 14643048
    [No Abstract]   [Full Text] [Related]  

  • 45. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries.
    Suba EJ; Murphy SK; Donnelly AD; Furia LM; Huynh ML; Raab SS
    Am J Public Health; 2006 Mar; 96(3):480-7. PubMed ID: 16449592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of a hospital based cytology screening programme for reduction in life time risk of cervical cancer.
    Agarwal SS; Murthy NS; Sharma S; Sharma KC; Das DK
    Neoplasma; 1995; 42(2):93-6. PubMed ID: 7617084
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Papanicolaou screening in developing countries.
    Goldhaber-Fiebert JD
    Am J Clin Pathol; 2005 Aug; 124(2):314-5; author reply 315-6. PubMed ID: 16116686
    [No Abstract]   [Full Text] [Related]  

  • 48. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries.
    Suba EJ
    Clin Lab Med; 2004 Dec; 24(4):945-63. PubMed ID: 15555750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Papanicolaou screening in developing countries: an idea whose time has come.
    Suba EJ; Raab SS;
    Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comment on "New paradigm for prevention of cervical cancer" [Eur J Obstet Gynecol Reprod Biol 2007;130(1):25-9].
    Mahajan NN; Gaikwad NL; Soni RN; Mahajan KN
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):140-1; author reply 141. PubMed ID: 17524549
    [No Abstract]   [Full Text] [Related]  

  • 51. Chapter 8: Screening for cervical cancer in developing countries.
    Denny L; Quinn M; Sankaranarayanan R
    Vaccine; 2006 Aug; 24 Suppl 3():S3/71-7. PubMed ID: 16950020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prophylaxis and screening of precancer and cancer of the uterine cervix in the XXI century].
    Kostova P; Zlatkov V
    Akush Ginekol (Sofiia); 2009; 48(1):41-5. PubMed ID: 19496464
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervical cancer screening in north-east Scotland.
    Macgregor JE; Moss S; Parkin DM; Day NE
    IARC Sci Publ; 1986; (76):25-36. PubMed ID: 3570409
    [No Abstract]   [Full Text] [Related]  

  • 54. Assessing the HPV vaccine: researchers confront complex interplay of factors.
    Tuma RS
    J Natl Cancer Inst; 2009 Apr; 101(7):444-5. PubMed ID: 19318636
    [No Abstract]   [Full Text] [Related]  

  • 55. [Model program for the prevention and detection of gynecologic cancer in developing countries].
    Goes JS; Goes JC
    Bol Oficina Sanit Panam; 1980 Nov; 89(5):397-408. PubMed ID: 6452131
    [No Abstract]   [Full Text] [Related]  

  • 56. Cost-effectiveness of cervical-cancer screening in five developing countries.
    Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
    N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Cervical cancer in developing countries. A threat to reproductive health].
    Tristen C; Bergström S
    Lakartidningen; 1996 Sep; 93(39):3374-6. PubMed ID: 8926808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Socioeconomic status and cancer screening.
    Segnan N
    IARC Sci Publ; 1997; (138):369-76. PubMed ID: 9353678
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cervical screening. Testing times.
    Dignan K
    Nurs Times; 1993 Nov 3-9; 89(44):28-30. PubMed ID: 8233961
    [No Abstract]   [Full Text] [Related]  

  • 60. [Organizational model of gynecologic cytodiagnostics].
    Obrapalska E; Popowicka L; Helbich A; Kostyrka J
    Ginekol Pol; 1976 Sep; 47(9):1075-7. PubMed ID: 992470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.